SYS-CON MEDIA Authors: Jason Bloomberg, Liz McMillan, Pat Romanski, Elizabeth White, Javier Paniza

News Feed Item

MarketVIEW: Hepatitis B virus vaccines

NEW YORK, Dec. 24, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

MarketVIEW: Hepatitis B virus vaccines

http://www.reportlinker.com/p01934498/MarketVIEW-Hepatitis-B-virus-vacci...

Hepatitis B virus (HBV) is transmitted by exposure to infectious blood or body fluids by percutaneous or mucosal means. Transmission occurs usually amongst adults exhibiting risk behaviours e.g. IDUs, MSM and heterosexuals with multiple partners although vertical transmission can occur from mother to child at birth. The HBV virus is more infectious than HIV and can cause chronic infection, resulting in cirrhosis of the liver, liver cancer, liver failure, and death. It is estimated that 2 billion people worldwide have been infected with the virus and about 600 000 people die every year due to the consequences of hepatitis B (WHO Figures).

This MarketVIEW is a comprehensive MS Excel-based model + summary presentation which forecasts the potential commercial value of Hepatitis B Virus (HBV) vaccines across major Western markets until 2030. The model contains value ($ m) and volume (mio doses) predictions per product type along with timeframe, pricing and penetration estimates for all adult risk groups and infants vaccination (where policy in place). The product also includes three different scenarios for the potential penetration of Dynavax's new HBV vaccine Heplisav and gives estimates of potential revenues to 2030.

THIS PRODUCT IS A EXECUTIVE PRESENTATION + 3 MODELS

Author's note

Executive Summary

Heplisav: market revenues to 2030 ($m) – SCENARIO 1

Heplisav: market revenues to 2030 ($m) – SCENARIO 2

Heplisav: market revenues to 2030 ($m) – SCENARIO 3

Existing HBV vaccines: revenues by vaccine type

Existing HBV vaccines: revenues by market (all types)

Existing HBV vaccines: revenues by market (monovalent)

Existing HBV vaccines: revenues by market (Twinrix)

Existing HBV vaccines: revenues by risk group (all types)

Existing HBV vaccines: revenues by risk group (monovalent)

Existing HBV vaccines: revenues by risk group (Twinrix)

Existing HBV vaccines: volume (all types)

Commercial model: key assumptions

Overview of modeling strategy

Target populations

Healthcare workers: modeling strategy

Travelers: modeling strategy

Diabetics: modeling strategy, US

Infants: modeling strategy

Other "at risk" populations: modelling strategy

Pricing and reimbursement

Pricing assumptions

Reimbursement polices: per major risk group/country

Vaccine market share split per country

At risk populations per country

HBV vaccine coverage by country

HBV background

HBV epidemiology summary

HBV global epidemiology

US: incident cases and risk exposures

Europe: HBV incident cases

Hepatitis B vaccines and dosing schedules

Merck & Co and GSK hepatitis vaccine sales, 2005-2011

National HBV vaccine policies

Heplisav overview

Bibliography

About VacZine Analytics

Disclaimer

PAGES: ~65 MS PowerPoint slides, fully referenced/sourced. Available in .pdf form

Contents – Vaccine demand models (MS Excel-based)

Title sheet CHARTS – VALUE CHARTS – VOLUME Heplisav sales forecast Country value summary Value adults (all) Value adults (monovalent) Value (Twinrix) Volume Adult worksheets ? US (adults) Canada (adults) Australia (adults) France (adults) Germany (adults) Italy (adults) Spain (adults) UK (adults) Spain (adults) Adult worksheets ? US (infants) Canada (infants) Australia (infants) Europe universal (infants) Europe at risk (infants) Source material ? Births Total populations 18-49 yrs Global price summary At risk variables Public/private split Monovalent combi split ESRD incidence Trips to HBV endemic countries Travel market variables HBV cases US HBV cases US by risk group HBV cases US Diabetes Pneumo vaccine coverage Sales data Back page

Worksheets = 65 interconnected

To order this report: MarketVIEW: Hepatitis B virus vaccines http://www.reportlinker.com/p01934498/MarketVIEW-Hepatitis-B-virus-vaccines.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001

 

 

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
In a world of ever-accelerating business cycles and fast-changing client expectations, the cloud increasingly serves as a growth engine and a path to new business models. Dynamic clouds enable businesses to continuously reinvent themselves, adapting their business processes, their service and software delivery and their operations to achieve speed-to-market and quick response to customer feedback. As the cloud evolves, the industry has multiple competing cloud technologies, offering on-premises ...
DevOps means different things to different people. Qubell defines DevOps as the ability for the developer teams to do what they need to do to have this level of self-service. At DevOps Summit, Stan Klimoff, CTO of Qubell, demos the enterprise DevOps platform.
SYS-CON Events announced today that that Innodisk, the service-driven provider of industrial embedded flash and DRAM storage products and technologies, will exhibit at SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. Innodisk is a service-driven provider of industrial embedded flash and DRAM storage products and technologies. With satisfied customers across the embedded, aerospace and defense, cloud storage markets an...
The 3rd International Internet of @ThingsExpo, co-located with the 16th International Cloud Expo - to be held June 9-11, 2015, at the Javits Center in New York City, NY - announces that its Call for Papers is now open. The Internet of Things (IoT) is the biggest idea since the creation of the Worldwide Web more than 20 years ago.
Connected devices and the Internet of Things are getting significant momentum in 2014. In his session at Internet of @ThingsExpo, Jim Hunter, Chief Scientist & Technology Evangelist at Greenwave Systems, examined three key elements that together will drive mass adoption of the IoT before the end of 2015. The first element is the recent advent of robust open source protocols (like AllJoyn and WebRTC) that facilitate M2M communication. The second is broad availability of flexible, cost-effective ...
"Our premise is Docker is not enough. That's not a bad thing - we actually love Docker. At ActiveState all our products are based on open source technology and Docker is an up-and-coming piece of open source technology," explained Bart Copeland, President & CEO of ActiveState Software, in this SYS-CON.tv interview at DevOps Summit at Cloud Expo®, held Nov 4-6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
The Internet of Things will put IT to its ultimate test by creating infinite new opportunities to digitize products and services, generate and analyze new data to improve customer satisfaction, and discover new ways to gain a competitive advantage across nearly every industry. In order to help corporate business units to capitalize on the rapidly evolving IoT opportunities, IT must stand up to a new set of challenges. In his session at @ThingsExpo, Jeff Kaplan, Managing Director of THINKstrateg...
"There is a natural synchronization between the business models, the IoT is there to support ,” explained Brendan O'Brien, Co-founder and Chief Architect of Aria Systems, in this SYS-CON.tv interview at the 15th International Cloud Expo®, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
The Internet of Things will greatly expand the opportunities for data collection and new business models driven off of that data. In her session at @ThingsExpo, Esmeralda Swartz, CMO of MetraTech, discussed how for this to be effective you not only need to have infrastructure and operational models capable of utilizing this new phenomenon, but increasingly service providers will need to convince a skeptical public to participate. Get ready to show them the money!
Eighty-five percent of companies store information in some sort of unstructured manner. In this demo at 15th Cloud Expo, Mark Fronczak, Product Manager at Solgenia, discussed their enterprise content management solution, which was created to help companies organize and take control of their digital assets.
The BPM world is going through some evolution or changes where traditional business process management solutions really have nowhere to go in terms of development of the road map. In this demo at 15th Cloud Expo, Kyle Hansen, Director of Professional Services at AgilePoint, shows AgilePoint’s unique approach to dealing with this market circumstance by developing a rapid application composition or development framework.
Fundamentally, SDN is still mostly about network plumbing. While plumbing may be useful to tinker with, what you can do with your plumbing is far more intriguing. A rigid interpretation of SDN confines it to Layers 2 and 3, and that's reasonable. But SDN opens opportunities for novel constructions in Layers 4 to 7 that solve real operational problems in data centers. "Data center," in fact, might become anachronistic - data is everywhere, constantly on the move, seemingly always overflowing. Net...
Leysin American School is an exclusive, private boarding school located in Leysin, Switzerland. Leysin selected an OpenStack-powered, private cloud as a service to manage multiple applications and provide development environments for students across the institution. Seeking to meet rigid data sovereignty and data integrity requirements while offering flexible, on-demand cloud resources to users, Leysin identified OpenStack as the clear choice to round out the school's cloud strategy. Additional...

ARMONK, N.Y., Nov. 20, 2014 /PRNewswire/ --  IBM (NYSE: IBM) today announced that it is bringing a greater level of control, security and flexibility to cloud-based application development and delivery with a single-tenant version of Bluemix, IBM's

“We are strong believers in the DevOps movement and our staff has been doing DevOps for large enterprise environments for a number of years. The solution that we build is intended to allow DevOps teams to do security at the speed of DevOps," explained Justin Lundy, Founder & CTO of Evident.io, in this SYS-CON.tv interview at DevOps Summit, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.